Uniphar plc
Directorate Change
Dublin, London | 30 January
2024: Uniphar plc (the "Company" or
"Uniphar"), an international diversified healthcare services
business addressing the needs of more than 200 multinational
pharmaceutical and medical technology manufacturers, is pleased to
announce the appointment of Valerie Sick to its Board as an
independent non-executive Director, with immediate
effect.
Valerie has over 25 years' senior
international experience in private and publicly listed
pharmaceutical and life science companies in Europe. She has held
senior financial and management roles, including managing very
diverse operations from a profitability and value creation point of
view. Valerie currently serves as Chief Financial Officer of
bioMerieux Deutschland GmbH and previous appointments include
Director of Finance and Administration of Yves Rocher GmbH and
Global Process Owner - Finance for Celesio AG. She is highly
experienced in strategic change management and integration across
multiple countries and regions to foster growth, with extensive
experience in managing multi-stakeholder engagement and strategic
decision-making within complex regulated environments at global,
regional and national levels. Valerie is fluent in French, German
and English and also has a strong interest in climate friendly
business models and long-term sustainable business.
Committee Changes
The Company also announces the
following non-executive director changes to the composition of the
Committees of the Board with immediate effect:
· Valerie Sick has been appointed to the Nominations, Governance
and Sustainability Committee and the Remuneration
Committee.
· Paul
Hogan has been appointed as Chair of the Remuneration Committee
following the resignation of Jeffrey Berkowitz.
The updated composition of the
Committees of the Board will be available on the Company's
website: www.uniphar.com.
Maurice Pratt, Chairman of Uniphar plc,
commented:
"I
am delighted to welcome Valerie to the Board of Uniphar where I
believe she will bring extensive commercial and international
markets experience and complement the existing skills and expertise
of our Board. I, along with the rest of the Board, look forward to
working with Valerie as Uniphar seeks to deliver on the significant
growth opportunity ahead."
Additional Information:
Valerie Christine Sick (French
citizen, aged 52 years) does not hold any ordinary shares or
options in the Company. The Company confirms that there is no other
information that is required to be disclosed under Schedule 2(g) of
the AIM Rules for Companies.
--- ENDS ---
Contact details
|
Uniphar Group
|
Tel: +353 (0) 1 428
7777
|
|
Allan Smylie, Head of
Strategy and IR
|
|
|
|
Davy (Joint Corporate Broker, Nominated Advisor
and
Euronext Growth Listing Sponsor)
|
Tel: +353 (0) 1 679
6363
|
|
Daragh
O'Reilly
Niall
Gilchrist
Ivan Murphy
|
|
|
|
|
|
RBC Capital Markets (Joint Corporate
Broker)
|
Tel: +44 (0) 20 7653
4000
|
|
Jamil Miah
Rupert
Walford
|
|
|
|
|
|
Stifel Nicolaus Europe Limited (Joint
Corporate Broker)
|
Tel:
+44 (0) 20 7710 7600
|
|
Matt Blawat
Ben
Maddison
Francis
North
|
|
|
|
|
|
Q4 PR
|
Tel: +353 (0) 1 475
1444
|
|
Iarla Mongey, Public
Relations Advisor to Uniphar Group
|
|
About Uniphar plc
Headquartered in Dublin, Ireland,
the Uniphar Group is an international diversified healthcare
services business servicing the requirements of more than 200
multinational pharmaceutical and medical technology manufacturers
across three divisions - Uniphar Pharma, Uniphar Medtech and
Uniphar Supply Chain & Retail. The Group is active in Europe,
North America, APAC and MENA and delivers to 160+
counties.
The Company's vision is to improve
patient access to pharmaco-medical products and treatments by
enhancing connectivity between manufacturers and healthcare
stakeholders. Uniphar represents a strong combination of scale,
growth, and profitability.
Uniphar Supply Chain & Retail
Uniphar Supply Chain and Retail is
the leading pharmaceutical wholesaler in Ireland with a growing
symbol group offering of retail pharmacies. The Group's strategy
for Uniphar Supply Chain and Retail is to grow our wholesale market
share, our symbol group network and our own brand, in-licenced and
consumer products portfolio.
Uniphar Medtech
Uniphar Medtech is a leading
Pan-European medical device distributor and solutions partner. The
Group's strategy for Uniphar Medtech is to grow our service
offering across Europe and expand our addressable market by serving
new specialities and new manufacturers.
Uniphar Pharma
Uniphar Pharma operates a global business with high value services
across the lifecycle of a pharmaceutical product. We enable pharma
and biotech companies to bring innovative medicines to global
markets and provide healthcare professionals with access to
medicines they can’t source through traditional channels. Our
strategy is to build a leading platform to provide the specialist
support and expertise needed to improve access to these
medicines.
